Renovaro INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

Lunai Bioworks, Inc. is holding a special meeting on May 4, 2026, to seek stockholder approval for a reverse stock split aimed at maintaining its Nasdaq listing.
Lunai Bioworks, Inc. will hold its 2025 Annual Meeting to vote on key governance matters, including an expanded equity incentive plan, as the company navigates significant net losses and recent dilutive debt restructuring.
Renovaro Inc. is seeking shareholder approval for a reverse stock split ranging from 1-for-3 to 1-for-10 to regain compliance with Nasdaq's minimum bid price requirement and avoid delisting.